Escherichia coli K88 receptor expression in intestine of disease-susceptible weaned pigs.
A challenge trial was carried out in which Escherichia coli O157 K88ac was administered to a litter of weaned pigs and the development of the disease monitored over a five-day experimental period. The eight animals in the trial were assigned to two groups depending on whether they exhibited disease symptoms. Six pigs developed diarrhoea and two appeared unaffected; these were designated as the test (or K88-susceptible) group and the control (or K88-resistant) group, respectively. The animals were euthanised and the intestine was removed and sections processed for brush border membrane vesicle preparation. Microscopic and biochemical assays were undertaken on tissue samples from each animal and a strong correlation was observed between the expression of a glycoprotein receptor complex associated with the brush border membrane and the development of disease symptoms. Further investigation revealed the presence of an analogous glycoprotein complex in the K88-resistant group which did not bind the K88-fimbriae antigen. These results suggest that genetic differences in the glycosyl moieties of the receptor complex provide the basis for disease susceptibility to K88-positive E. coli.
Jeyasingham
M D
MD
Rowett Research Institute, Bucksburn, Aberdeen, UK. mdj@rri.sari.ac.uk
Butty
P
P
King
T P
TP
Begbie
R
R
Kelly
D
D
D000818:Animals; D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial; D000954:Antigens, Surface / Q000378:metabolism*; D001422:Bacterial Adhesion / Q000276:immunology; D002241:Carbohydrates / Q000032:analysis; D002852:Chromatography, Ion Exchange / Q000662:veterinary; D015169:Colony Count, Microbial / Q000662:veterinary; D003967:Diarrhea / Q000276:immunology / Q000382:microbiology / Q000662:veterinary; D004198:Disease Susceptibility; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D004927:Escherichia coli Infections / Q000276:immunology / Q000662:veterinary*; D019453:Escherichia coli O157 / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity*; D029968:Escherichia coli Proteins; D005243:Feces / Q000382:microbiology; D036781:Fimbriae Proteins; D010861:Fimbriae, Bacterial / Q000276:immunology / Q000378:metabolism; D019084:Fluorescent Antibody Technique, Indirect / Q000662:veterinary; D005767:Gastrointestinal Diseases / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D006386:Hemagglutination Tests / Q000662:veterinary; D007104:Immune Adherence Reaction / Q000662:veterinary; D007150:Immunohistochemistry; D007422:Intestines / Q000276:immunology / Q000382:microbiology; D008871:Microvilli / Q000276:immunology / Q000378:metabolism; D011946:Receptors, Antigen / Q000378:metabolism*; D013552:Swine; D013553:Swine Diseases / Q000276:immunology / Q000382:microbiology*
D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D002241:Carbohydrates; D029968:Escherichia coli Proteins; C026888:K88 antigen, E coli; D011946:Receptors, Antigen; D036781:Fimbriae Proteins